Abstract
In an open, clinical trial comprising a total of 21 depressed in-patients (6 men and 15 women) citalopram was administered in doses of 20-60 mg once daily for a period of at least 3 weeks. Fourteen of the patients were treated for 4 weeks, and 6 of these patients were treated for another 2 weeks. The CPRS subscale for depression (MADRS) and a global evaluation were used for assessment of the therapeutic effect. Twelve patients showed complete or partial response to treatment, and generally onset of therapeutic effect was seen within the first 2 weeks of treatment. Side-effects were generally few and mild, anxiety being the most frequent one. No pathological laboratory values were recorded, and apart from one case of slight and transient bradycardia no changes were observed in the cardiovascular parameters. Determination of plasma levels in 16 of the patients under presumed steady-state conditions showed an inter-individual variation between 28 and 616 nM/l for citalopram and between 32 and 338 nM/l for its monodemethylated metabolite for daily citalopram doses of 30-60 mg. The average ratio citalopram-desmethyl citalopram was 1.70. No correlation was found between clinical response and the plasma levels.
Citations
Dec 25, 2010·Psychopharmacology·Jianwei JiaoStephanie C Dulawa
Jul 2, 1993·Journal of Chromatography·P ReymondP Baumann
Jan 12, 1996·Journal of Chromatography. B, Biomedical Applications·O V Olesen, K Linnet
Sep 5, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·K Brøsen, C A Naranjo
Dec 20, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Mugdha ThakurDavid B Matchar
Aug 28, 2009·PloS One·Gerard HonigLaurence H Tecott
May 3, 2008·Mayo Clinic Proceedings·Orhan OnalanLutfu Bekar
Oct 17, 2015·Neuropharmacology·Wanhong ZuoJiang-Hong Ye
Jun 13, 2016·Mayo Clinic Proceedings·Malik NassanMark A Frye
Jan 29, 2003·Psychopharmacology·Gregers WegenerRaben Rosenberg
Aug 15, 2014·Journal of Psychopharmacology·Yingying KumarGen Shinozaki
May 1, 2004·Journal of Clinical Psychopharmacology·Georg NikischPierre Baumann
Oct 3, 1999·Journal of Clinical Psychopharmacology·J WillettsB Beer
Feb 18, 2005·International Journal of Geriatric Psychiatry·Maria Stella T GironBengt Winblad
Apr 25, 2000·Therapeutic Drug Monitoring·B B Rasmussen, K Brøsen
Sep 26, 2003·Therapeutic Drug Monitoring·Yves Le Bloc'hPierre Baumann
Sep 1, 1989·Pain·G EberhardU Sundequist
Mar 15, 1990·Cancer·A LiptonR J Santen
Jan 1, 1995·Chirality·B RochatP Baumann
Oct 27, 2001·Journal of Neuroendocrinology·J B JensenJ D Mikkelsen
Jan 17, 2002·The Annals of Pharmacotherapy·G K IsbisterA Foy
May 13, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·C B EapC Hiemke
Dec 14, 2002·Brain Research·Gregers WegenerRaben Rosenberg